TAVR: CKD & patient mortality | Prosthetic-patient mismatch

News You Need to Know Today

Wednesday, December 15, 2021

Editor's Choice: TAVR

Certain patients with chronic kidney disease face a higher risk of death after TAVR

No such trend was reported among patients with end-stage kidney disease.

Certain patients with chronic kidney disease face a higher risk of death after TAVR

No such trend was reported among patients with end-stage kidney disease.

Prosthetic-patient mismatch after TAVR much less likely among Asian patients

Patient outcomes, it seems, are not significantly impacted by this trend.

In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.

Prosthetic-patient mismatch after TAVR much less likely among Asian patients

Patient outcomes, it seems, are not significantly impacted by this trend.

Pre-TAVR pulmonary artery dilatation helps identify high-risk patients

Imaging-based PAD may provide value as a noninvasive alternative to right heart catheterization.

Pre-TAVR pulmonary artery dilatation helps identify high-risk patients

Imaging-based PAD may provide value as a noninvasive alternative to right heart catheterization.

Patient frailty not a key factor when choosing between TAVR and SAVR

Frailty measurements may still provide helpful information in other ways, of course.

Hackensack Meridian Health, New Jersey’s largest health network, recently announced it has signed a definitive agreement with Complete Care to acquire a majority of its long-term care facilities.

Patient frailty not a key factor when choosing between TAVR and SAVR

Frailty measurements may still provide helpful information in other ways, of course.

What new research tells us about TAVR and platelet-to-lymphocyte ratios

The blood-based biomarker was previously associated with worse acute coronary syndrome outcomes. What does it mean for TAVR patients?

IVUS guidance during DES implantation boosts long-term outcomes in new study

What new research tells us about TAVR and platelet-to-lymphocyte ratios

The blood-based biomarker was previously associated with worse acute coronary syndrome outcomes. What does it mean for TAVR patients?

In Case You Missed It

5 years later, TAVR still delivering strong results for intermediate-risk patients

Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years.

5 years later, TAVR still delivering strong results for intermediate-risk patients

Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years.

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

TAVR: CKD & patient mortality | Prosthetic-patient mismatch

Editor's Choice: TAVR

In Case You Missed It

Recent Newsletters